ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,039.17
      1.36%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Immupharma Plc (IMM)

      7. Immupharma Plc (IMM) News

      IMM

      Immupharma (IMM)

      Immupharma Plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:IMM
      DateTimeSourceHeadlineSymbolCompany
      03/28/20182:01AMUK RegulatoryImmupharma PLC Appointment of Joint BrokerLSE:IMMImmupharma Plc
      03/23/20187:17AMAlliance NewsAlliance NewsImmuPharma Prepares To Report Lupuzor Study Results In AprilLSE:IMMImmupharma Plc
      03/23/20183:00AMUK RegulatoryImmupharma PLC Lupuzor Pivotal Phase III Study UpdateLSE:IMMImmupharma Plc
      03/05/201811:13AMUK RegulatoryImmupharma PLC AIM Notice (17)LSE:IMMImmupharma Plc
      02/15/20182:01AMRNS Non-RegulatoryImmupharma PLC London Investor EveningLSE:IMMImmupharma Plc
      02/09/20189:00AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      02/07/20184:35AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      02/05/20182:00AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      01/31/20185:23AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      01/24/20185:42AMAlliance NewsAlliance NewsImmuPharma Raises GBP10 Million To Support Future Investments (ALLISS)LSE:IMMImmupharma Plc
      01/24/20182:00AMUK RegulatoryImmupharma PLC Successful Placing to Raise £10 MillionLSE:IMMImmupharma Plc
      01/18/20188:34AMAlliance NewsAlliance NewsImmuPharma Completes Lupizor Phase III Clincial TrialLSE:IMMImmupharma Plc
      01/18/20182:00AMUK RegulatoryImmupharma PLC Completion of LupuzorT Pivotal Phase III StudyLSE:IMMImmupharma Plc
      12/21/20172:05AMUK RegulatoryImmupharma PLC Grant of OptionsLSE:IMMImmupharma Plc
      12/21/20172:00AMUK RegulatoryImmupharma PLC Last patient completes dosing in LupuzorT TrialLSE:IMMImmupharma Plc
      11/28/20177:00AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      11/24/20178:32AMUK RegulatoryImmupharma PLC Grant of OptionsLSE:IMMImmupharma Plc
      11/02/20175:09AMAlliance NewsAlliance NewsImmuPharma Phase III Lupuzor Trial On Track As 58% Complete StudyLSE:IMMImmupharma Plc
      11/02/20173:34AMAlliance NewsAlliance News*Lupuzor Sees Continued "Robust" Safety Record In Phase III TrialLSE:IMMImmupharma Plc
      11/02/20173:33AMAlliance NewsAlliance News*ImmuPharma Expects Top Line Results To Be Out In Q1 2018LSE:IMMImmupharma Plc
      11/02/20173:33AMAlliance NewsAlliance News*ImmuPharma Says 58% Of Patients Past 12M Stage In Lupuzor TrialLSE:IMMImmupharma Plc
      11/02/20173:33AMAlliance NewsAlliance News*ImmuPharma Says All Patients Past 9M Stage In Lupuzor TrialLSE:IMMImmupharma Plc
      11/02/20173:00AMUK RegulatoryImmupharma PLC Update on LupuzorT Pivotal Phase III StudyLSE:IMMImmupharma Plc
      10/16/201710:29AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      10/04/20175:53AMAlliance NewsAlliance NewsImmuPharma Nets Over GBP5.0 Million In Completed Lanstead Agreement (ALLISS)LSE:IMMImmupharma Plc
      10/04/20172:00AMUK RegulatoryImmupharma PLC Completion of Lanstead Sharing AgreementLSE:IMMImmupharma Plc
      09/27/20176:10AMAlliance NewsAlliance NewsImmuPharma Focused On Lupuzor Development As Interim Loss NarrowsLSE:IMMImmupharma Plc
      09/27/20172:00AMUK RegulatoryImmupharma PLC Interim ResultsLSE:IMMImmupharma Plc
      09/26/20174:56AMAlliance NewsAlliance NewsImmuPharma Prepares Regulatory Filings Ahead Of Lupuzor Trial ResultsLSE:IMMImmupharma Plc
      09/26/20172:00AMUK RegulatoryImmupharma PLC Preparation of Lupuzor'sT Regulatory SubmissionsLSE:IMMImmupharma Plc
       Showing the most relevant articles for your search:LSE:IMM